play tumblr googleplus facebook twitter youtube vimeo linkedin instagram
I live inside the U.S. Outside the U.S.
In the European Union, the Lumee™ Oxygen Platform is CE Marked. In the United States, the Lumee Oxygen Platform is an Investigational Device Limited by Federal Law to Investigational Use.

Profusa is pioneering tissue-integrating biosensors for continuous monitoring of body chemistries.

News & Events

Leading global investors join this round; financing will accelerate commercialization of Lumee™ Oxygen Platform and pioneering glucose biosensors ...

Novel microsensing technology that reflects microvascular perfusion and oxygen supply in tissue shows promise in patients with chronic limb-threatening ischemia.

NEW ORLEANS, March 19, 2018 — Up until now, local inflammation and scar tissue from the so-called “foreign body response” has prevented ...

We are becoming more accustomed to continually tracking health metrics with smart wearable devices. The next step will ...

Leading Healthcare Authority and Public Health Advocate to Advise Developer of Tissue-integrated Sensors for Real-time Monitoring of Body ...

Ben Hwang, Chairman and CEO at Profusa, spoke to LLAMA host, Peter Bowes, at TEDMED in California. LLAMA, ...

Presentation by Profusa’s CEO Ben Hwang at TEDMED The Hive on Thursday, December 1, 2016. What if we ...

First Clinical Application Aimed At Oxygen Monitoring of Compromised Tissues in PAD SOUTH SAN FRANCISCO, Calif., October 3, ...